ABSTRACT: Heterotopic ossification (HO) develops in the extremities of wounded service members and is common in the setting of high-energy penetrating injuries and blast-related amputations. No safe and effective prophylaxis modality has been identified for this patient population. Palovarotene has been shown to reduce bone formation in traumatic and genetic models of HO. The purpose of this study was to determine the effects of Palovarotene on inflammation, progenitor cell proliferation, and gene expression following a blastrelated amputation in a rodent model (n ¼ 72 animals), as well as the ability of Raman spectroscopy to detect early HO before radiographic changes are present. Treatment with Palovarotene was found to dampen the systemic inflammatory response including the cytokines IL-6 (p ¼ 0.01), TNF-a (p ¼ 0.001), and IFN-g (p ¼ 0.03) as well as the local inflammatory response via a 76% reduction in the cellular infiltration at post-operative day (POD)-7 (p ¼ 0.03). Palovarotene decreased osteogenic connective tissue progenitor (CTP-O) colonies by as much as 98% both in vitro (p ¼ 0.04) and in vivo (p ¼ 0.01). Palovarotene treated animals exhibited significantly decreased expression of osteo-and chondrogenic genes by POD-7, including BMP4 (p ¼ 0.02). Finally, Raman spectroscopy was able to detect differences between the two groups by POD-1 (p < 0.001). These results indicate that Palovarotene inhibits traumatic HO formation through multiple inter-related mechanisms including anti-inflammatory, anti-proliferative, and gene expression modulation. Further, that Raman spectroscopy is able to detect markers of early HO formation before it becomes radiographically evident, which could facilitate earlier diagnosis and treatment. ß
Heterotopic ossification (HO) is exceedingly common following wartime trauma, particularly after blast injuries. It occurs even more frequently among service members sustaining combat-related amputations with as many as 60-65% of these patients eventually developing HO, 1,2 particularly after blast injuries, which accounted for 75% of combat casualties from 2005 to 2009. 3 The formation of HO within salvaged and residual limbs of injured service members can be challenging, 4 and symptomatic HO is a common indication for elective revision amputation surgery in this patient population. 5 While surgical excision of HO is generally effective, 6 it is not without risks. Pavey et al. reported a series of 172 HO excisions and found that 31% resulted in a complication requiring a return to the operating room, with infection being the most common reason. 7 Prophylaxis with either externalbeam radiation therapy or non-steroidal anti-inflammatory drugs (NSAIDs) has typically been avoided due to logistical infeasibility or risk of side-effects in polytrauma patients. 6 As such, recent years have seen an emphasis on the discovery and characterization of improved interventions for the prevention and treatment of combat-related HO.
HO typically forms via endochondral ossification which requires the formation of a cartilage anlage that is replaced by a bony matrix. 8, 9 In the case of traumatic HO, an inciting event produces a dysregulated systemic inflammatory response which drives the local inflammatory response. [8] [9] [10] A blast mechanism increases the risk of HO in combat injured patients 1 and blast overpressure increases the severity of HO formed in an animal model. 11 Combat-injured service members have also been shown to demonstrate significant alterations in local and systemic inflammatory biomarkers which correlated with the formation of HO. [12] [13] [14] The inhibition of retinoic acid (RA) signaling is critical in early chondrogenesis and subsequent skeletal development. [15] [16] [17] During normal endochondral ossification, BMPs induce reductions in endogenous RA signaling which in turn allows chondrocyte differentiation and proliferation. 17, 18 When RAR agonists are introduced they inhibit chondrogenesis. 17, 18 Palovarotene, a potent RAR-g agonist, is particularly effective in preventing chondrogenesis and HO in both a genetic model of fibrodysplasia ossificans progressiva (FOP) as well as in an animal model of combat-related HO. [19] [20] [21] In addition to its effects on chondrogenesis, RA is also a potent inhibitor of inflammatory cytokine expression [22] [23] [24] ; this anti-inflammatory effect may provide another mechanism of HO inhibition.
While much of the research performed over the past decade has been focused on the characterization and prevention of HO, there is an emerging interest in early diagnosis. Traditionally, HO is diagnosed by conventional radiographic imaging. This can delay diagnosis as it may not be visible on conventional or high-resolution radiographic imaging until 3-4 weeks after injury, while histological evidence demonstrates chondrogenesis and tissue mineralization much earlier. 25, 26 In a previous study, we employed tissue mapping of histologically sectioned tissue in regions containing non-radiographic microscopic evidence of HO formation in our blast injury model at PODs 7, 14, and 21 to characterize the earliest detectable changes associated with HO formation using Raman spectroscopy. 27 Collagen and proteoglycan production were identified in areas of chondrogenesis by POD-7 and collagen growth and maturation were observed in conjunction with immature osteoid deposition at POD-14 and 21, confirming spectroscopic markers of early HO formation seen in human combat injured HO tissue. 28 Non-invasively identifying early tissue changes during and preceding calcium deposition may make selective early intervention a more feasible option.
We have previously developed a well-characterized small animal model for combat-related HO. 11, 25, 29 This model simulates a blast injury by exposing an animal to blast overpressure, femur fracture, and a soft-tissue crush injury followed by an amputation through the zone of injury. Palovarotene treatment, in this model, resulted in inhibition of chondrogenesis and a decrease in HO formation. 21 Our previous study demonstrated the potency and therapeutic index of Palovarotene in suppressing trauma-induced HO. However, it is not clear whether Palovarotene treatment inhibits the proliferation or differentiation of multipotent connective tissue progenitor cells (CTPs) following a traumatic extremity injury. In this study, we sought to establish differences in the prevalence of osteogenic CTPs (CTP-Os) in vehicle control and Palovarotene treated injured animals as well as its effect on CTP-O proliferation in vitro. In addition, we attempted to identify the effect of Palovarotene on the inflammatory response and gene expression. Finally, by using Raman spectral imaging, we sought to identify the earliest detectable spectroscopic signatures associated with early HO development in intact tissue and to investigate the early effects of Palovarotene treatment.
METHODS

Animals
A total of 72 young adult pathogen-free male Sprague Dawley rats (Rattus norvegicus; 12-14 weeks, 400-500g) were purchased from Taconic Farms (Germantown, NY). Animals were housed in clean plastic cages and maintained on a 12-h light/dark cycle with unlimited access to food (standard rodent chow) and fresh water ad libitum. Animals were randomly assigned to experimental and control groups prior to the beginning of the study. The study protocol Rat Model for Combat-Related HO Sixty rats were randomly assigned to one of two treatment groups, Palovarotene or vehicle control (5% DMSO in corn oil), with six time points per group (n ¼ 5 rats/treatment group/time point). Twelve rats were used as na€ve controls and not exposed to injury. The 60 rats in the treatment groups were subjected to blast overpressure via a pneumatically driven shock tube (120 AE 7 kPa), femur fracture, soft tissue crush injury, and amputation through the zone of injury. Postoperative pain was managed using sustainedrelease buprenorphine (1.2 mg/kg) subcutaneously on the day of surgery with repeat dosing after 72-h, if needed, as previously described. 11, 25 Rats received via oral gavage (100 ml) of either Palovarotene (1.0 mg/kg; Atomax Chemicals, Shenzhen, China) or vehicle control every other day for 14 days beginning on POD)-1. Palovarotene purity confirmed greater than 98%. Postoperatively, rats were routinely monitored for signs of pain, weight loss, or wound complications and wounds that exhibited signs of infection or dehiscence were irrigated, d ebrided, and closed. 11, 25 Early euthanasia was performed if rats demonstrated a failure to thrive, persistent infection, or wound dehiscence after a third d ebridement. At study endpoint, rats were euthanized with pentobarbital (Fatal Plus; 390 mg/kg intraperitoneally; Patterson Veterinary, Devens, MA). Two rats died on POD-1, one from the 7 day vehicle control group and one from the 7 day Palovarotene group leaving a total of four animals in each of these two groups.
Serum Cytokine Analysis
Blood was collected on POD-1, 3, 7, 10, 14, and 21 by cardiac puncture, immediately following euthanasia. Serum from aged-matched, naïve rats was used for baseline measurements. Serum inflammatory mediators were measured using Luminex (Luminex Corporation, Austin, TX) multianalyte profiling technology (Bio-Plex Pro TM rat cytokine assay kit; Bio-Rad Laboratories, Hercules, CA) according to the manufacturer's instructions. The concentrations of 12 host markers including: interleukin (IL)-1b, IL-6, IL-10, IL-17, IL-18, granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage (GM)-CSF, interferon (IFN)-g, macrophage inflammatory protein (MIP)-1a, RANTES (regulated on activation, normal T cell expressed and secreted), tumor necrosis factor (TNF)-a, and monocyte chemoattractant protein (MCP)-1 were measured. The concentrations of all the analytes in the quality control reagents were found to be within the expected range. Results were extrapolated from a standard curve for each analyte.
Osteogenic Connective Tissue Progenitor Cell Proliferation
Biopsies of skeletal muscle were aseptically harvested from quadriceps muscle in the zone of injury surrounding the amputation site in Palovarotene and vehicle control-treated rats at POD-1, 3, 7, 10, 14, and 21. Briefly, samples devoid of fascia and fat, were weighed, thoroughly minced into a fine slurry, incubated in a solution of 300 U/ml of Collagenase Type II (Worthington, Lakewood, New Jersey) for 2 h at 37˚C and rigorously titrated to breakup large tissue fragments and release cells from intact fibers. After incubation the enzyme was inactivated by adding 10% fetal bovine serum (FBS). Cells were resuspended in osteogenic media consisting of alpha-minimum essential medium Eagle (a-MEM) with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, 10 À8 M dexamethasone, and 50 mg/ml ascorbate. Cell suspensions were serially filtered through 100 and 70 mm nylon filters, followed by determination of the cell count, using a cellometer (Nexcelom Biosciences, St. Lawrence, MA). Cells were plated at a density of 250-4,000 cells/ chamber (4.2 cm 2 ; Labtek chamber slides) with medium changes on days 1, 3, and 5. Cultures were maintained in a controlled proOx-C-chamber system (C-Chamber, C-374; Biospherix, Redfield, NY). The oxygen concentration was maintained at 21% with the residual gas mixture composed of 5% CO 2 and balance nitrogen for the duration of the experiments. On day 6, cultures were fixed with 10% neutral buffered formalin containing 0.5% cetylpyridinium chloride (CPC) for 10 min and stained with a nuclear stain (4,6-diamidino-2-phenylindole [DAPI]). Chambers were then scanned and analyzed using Colonyze TM software, identifying colonies containing eight or more cells in a well-defined cluster. Cellular concentration was defined as the number of isolated nucleated cells per gram of tissue. Total CTP concentration was defined as the number of CTP-Os per gram of tissue.
Effects of Palovarotene on CTP-O Proliferation In Vitro
Muscle-derived rat mesenchymal stem cells (rMSCs) from the quadriceps muscles of two naïve donor rats (2nd passage) were seeded in triplicate at a density of 1 Â 10 3 cells/well in 6-well plates in normal growth media (MesenCult Basal Medium, Lonza, Walkersville, MD) supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg of Fungizone (Lonza) for 24 h at 37˚C in fully humidified 5% CO 2 in air atmosphere. For the differentiation study group, normal growth media was changed to osteogenic media and supplemented with varying concentrations of Palovarotene (25, 50, 125 nM) or DMSO (125 nM) with media changes every 3 days. After 7 days, adherent cell colonies were rinsed twice with PBS, fixed with 100% methanol for 5 min at room temperature, air-dried, stained with Crystal violet solution for 5 min, and then rinsed with distilled water to remove residual dye. Colonies with greater than 25 cells/colony were counted using light microscopy by a reader (TAD) that was blinded to the treatment groups.
Gene Expression
At POD-7 and 14, small biopsies of skeletal muscle tissue surrounding the amputation site of five injured animals treated with either Palovarotene or vehicle control, were collected and stored in RNALater (Ambion Inc., Austin, TX) at 4˚C for 4 days before being removed and stored at À80˚C. Muscle tissue obtained from six age-matched, uninjured, and untreated rats served as na€ve controls. Total RNA was isolated and purified from muscle cell lysates using RNAeasy Lipid Tissue kits (Qiagen, Valencia, CA) and subsequently stored at À80˚C in nuclease-free water (Bio-Rad Laboratories). Total RNA was quantified spectroscopically using NanoDrop 1000 (ThermoFisher Scientific, Waltham, MA). Reverse transcriptase polymerase chain reaction (RT-PCR) was used to convert 1 mg of RNA to cDNA. Selected mRNA transcripts for 83 genes consisting of chondrogenic, osteogenic, angiogenic, and cell matrix targets were examined by quantitative real-time PCR (qPCR) using a custom low density microarray (Bio-Rad Laboratories). A list of all 83 target genes with a brief description of their function can be found in Supplementary Table S1 . Cycle Threshold (CT) values per gene transcript were normalized to the endogenous housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) within each sample and relative gene expression was calculated using the 2 ÀDDCt method. A gene was reported as differentially regulated if there was greater than a three-fold difference in expression compared to na€ve controls.
Raman Spectroscopy
At each time point, rats were euthanized and the intact soft tissue at the distal portion of the residual limb was examined via Raman Spectroscopy using a Kaiser Rxn1 PhAT probe 830 nm system (Kaiser Optical Systems, Inc., Ann Arbor, MI) and 6 mm diameter excitation spot size. Dark subtracted and intensity-corrected spectra were each acquired using 5 s acquisitions, 15 accumulations, and the cosmic ray removal feature. Two consecutive spectra were collected per animal in the same location. Reference spectra were acquired of harvested rat adipose tissue and naïve rat muscle and cortical bone. All processing of Raman data was performed in MATLAB 1 using custom-built scripts. Spectra were averaged per animal and smoothed using a seventh-order polynomial Savitzky-Golay filter, truncated to 600-1,750 cm À1 , baseline subtracted using a fifth-order polynomial fitting routine, and normalized to the methyl/methylene scissoring band at 1445 cm
À1
. Contribution of adipose tissue was removed from each spectrum using spectral subtraction of rat adipose reference signal. The contribution of mineralized tissue was removed using spectral subtraction of rat cortical bone reference signal as hydroxyapatite bone mineral within these experiments is attributable to both HO mineral and the signaling from the underlying femur due to thinning of the soft tissue coverage at the site of amputation, particularly in vehicle control animals, and the sampling depth capability of our Raman probe (2-3 mm).
Resulting adipose and bone subtracted spectra were analyzed for molecular markers of alterations in tissue composition characteristic of abnormal tissue pathology including the performance of spectral curve fitting using mixed Gaussian and Lorentzian functions of known Raman spectral bands and custom-built MATLAB 1 scripts. Band area ratios (BARs) were calculated using curve fit derived band areas and include the Amide III protein disorder/order (1240/[1270 þ 1300] cm À1 ) BAR, a measure of b-sheet and disordered protein over helical, ordered protein and (1240/ [1320 þ 1340] cm À1 ), a measure of b-sheet and disordered protein over CH 2 ,CH 3 twist and wag bands characteristic to muscle tissue.
Statistical Analysis
Statistical analysis was performed using SPSS v23 (SPSS Inc, Chicago, IL). Differences between cytokine levels were evaluated with a Student t-test. Differences in Raman BARs were evaluated across time and treatment using two-way ANOVA. Gene expression fold change data from treatment groups per time point were initially compared to na€ve tissue to assess a general injury effect with a one-way ANOVA. Effects of Palovarotene were evaluated across treatment PALOVAROTENE INHIBITS PROGENITOR CELL PROLIFERATION groups (vehicle or Palovarotene) and time (POD-7 and POD-14) using two-way ANOVA. Bonferroni was applied for all post hoc analyses. Equivariance was assessed with Levene's test. A statistical significance level was set at p < 0.05. Data are represented as mean AE standard error of the mean (SEM) unless otherwise specified.
RESULTS
Palovarotene Decreases the Systemic Inflammatory Response
Exposure to blast overpressure and a severe, polytraumatic extremity injury resulted in a rapid and prolonged inflammatory response in both the vehicle control and the Palovarotene treated groups (Figures 1  and 2) . 
Palovarotene Decreases Cellular Infiltration and CTP Proliferation In Vivo
The total number of isolated nucleated cells per gram of tissue in the vehicle control group increased through POD-7 (8.14 Â 10 6 AE 2.00 Â 
Palovarotene Decreases Chondrogenic and Osteogenic Gene Expression In Vivo
Gene expression for 83 mRNA transcripts (Supplemental Figure S1 ) consisting of chondrogenic, osteogenic, angiogenic, and cell matrix targets were examined by quantitative real-time PCR (qPCR) within soft tissue harvested from the amputation site at POD-7 and 14. Results were reported as fold change values, which are normalized relative increases (>1) or decreases (<1) in expression, compared to naïve tissue controls (¼1). One-way ANOVA analysis comparing average gene expression for all genes within each treatment group per time point to naïve controls, confirmed an injury effect (p ¼ 0.001). Two-way ANOVA analysis comparing average gene expression for all genes across treatment groups and time revealed a significant effect of Palovarotene treatment (p ¼ 0.0001) but not time (p < 0.310) compared to vehicle controls. While post hoc analysis showed the increase in average fold change of the vehicle controls was not significant (p ¼ 0.17), it confirmed these higher fold change values for vehicle controls were significant compared to Palovarotene treatment groups at both POD-7 (p ¼ 0.038) and POD-14 (p ¼ 0.0001) time points.
Two-way ANOVA analysis across treatment groups and time was used to assess the effects of Palovarotene treatment on expression of individual genes compared to vehicle controls. Generally, most genes showed no significant effect of times and significant differences in fold change were found between highly expressed vehicle controls and Palovarotene treated groups with lower fold change values. Post hoc analysis revealed the significance of most of these differentially regulated genes to be at POD-7. Palovarotene significantly downregulated the expression of BMP4 (p ¼ 0.006), as well as several positive regulators of osteogenesis, namely Ptk2
, and Itga1 (p ¼ 0.007) compared to vehicle controls ( Figure 6 ). Though most changes in gene expression were modest and exclusively seen in early stages of treatment, we observed a 668-fold increase in expression of CD44 (p ¼ 0.02) after 2 weeks of treatment compared to vehicle controls. Variable expression for genes between animals within the vehicle control group at POD-14 may explain why no other significant treatment differences were assessed at that time point as well as no significant effects of time on gene expression.
Raman Spectroscopy Detects Compositional Tissue Changes Associated With Early Heterotopic Ossification
Mean spectra of injured soft tissue illustrate compositional changes over 21 days following injury and differences between treatment groups ( Figure 7A ). Histological descriptions of the model employed following injury have been previously published for untreated 25 and Palovarotene treated animals. ) BAR, a semi-quantitative measure of the changes described, is significantly increased at POD-1 compared to Palovarotene treated animals (p < 0.001)( Figure 7B ). This is indicative of elevated b-sheet/random coil protein content suggestive of fibrin accumulation. 30 At POD-3, the Amide III protein disorder/order BAR decreases due to an increase in 1,270 cm À1 contribution suggesting clot remodeling. Further decreases are observed at POD-7 
PALOVAROTENE INHIBITS PROGENITOR CELL PROLIFERATION
DISCUSSION
These experiments revealed several key findings. First, Palovarotene leads to a significant reduction in both the systemic and the local inflammatory response to blast-related extremity injury. Serial serum cytokine analysis demonstrated alterations in the systemic inflammatory profile following treatment with Palovarotene. There was significant inhibition of many cytokines after treatment with Palovarotene at the POD-10 time point including IL-1b, IL-6, IL-10, IFN-g, and TNF-a which are all well-known proinflammatory mediators. Its anti-inflammatory effects can also be seen with the reduction in cellular infiltration. Following injury, the vehicle control treated animals saw a dramatic rise in the number of isolated nucleated cells per gram of tissue which continued until POD-7 where it reached a peak nearly four times higher than at POD-1. This increase likely represents the recruitment and infiltration of inflammatory cells into the site of injury, in response to chemotactic signals. The level of inflammatory infiltration in the Palovarotene treated animals never rose above the POD-1 values and was significantly lower than the vehicle control treated group at POD-7. The decreased level of cellular infiltration at the site of injury again indicates, as with the cytokine results, a decreased inflammatory response in the Palovarotene treated animals.
In addition to the anti-inflammatory effects, Palovarotene demonstrates anti-proliferative effects as well. The vehicle control treated animals demonstrated an increase in the CTP-O colonies following injury, which also rose through POD-7 to a maximum that was 16 times higher than the POD-1 values. This indicates an intense response of CTP-Os after a traumatic blast-related extremity injury. Palovarotene treated animals did not demonstrate any significant increase in the frequency of CTP-O and in fact, at POD-7 had a greater than 98% reduction in the number of CTP-O compared to the vehicle control treated animals. This decrease in CTP-O colony counts could be due to either a direct anti-proliferative effect on muscle-resident CTPs or due to a decrease in the mobilization and recruitment of progenitor cells to the site of injury following the decreased inflammatory response, or a combination of both. The direct antiproliferative effect of Palovarotene on muscle-resident CTPs was mimicked in the in vitro results, which revealed a dose-dependent inhibition of colony formation by CTPs isolated from na€ve, uninjured rats, seen under both growth and osteogenic differentiation media conditions. At the 125 nM concentration, Palovarotene exhibited a 94-98% reduction in colony formation compared to the untreated samples. The colonies formed also tended to be of a smaller size and with fewer cells per colony.
Furthermore, we detected significant alterations in chondro-and osteogenic gene expression in the remaining soft tissue at the amputation site of the Palovarotene treated animals, compared to corresponding tissue from vehicle treated animals. By POD-7, Palovarotene significantly decreased levels of chondro-and osteogenic gene expression, most notably Col4a3 and BMP4, compared to the vehicle control treatment group. We also found differential expression of genes involved in the production of extracellular matrix (e.g., CD44), indicating changes in tissue remodeling. CD44 is a membrane bound receptor for hyaluronic acid, an abundant extracellular matrix protein found in cartilage. The significant increase in expression of CD44 in the vehicle control group (688-fold) indicates increased chondrocyte-mediated extracellular matrix synthesis, an important step in the process of endochondral ossification, which is initiated by a cartilaginous anlage. Together, these results suggest that Palovarotene effectively targets key osteogenic and canonical signaling pathways during early stages of combat-related HO, resulting in significant reduction in ectopic bone formation at later stages.
The results presented within this work confirm the ability of Raman spectroscopy to detect the presence of collagen in intact tissue during early stages of endochondral ossification, within 1 week of injury, and represent the earliest measured collagen production. Collagen deposition as a spectroscopic marker of early HO formation was suggested by studies utilizing injured muscle biopsies collected from symptomatic HO lesions in combat injured patients. 28, 32 However, overt collagen signatures were not observed prior to histological and/or spectroscopic evidence of osteoid deposition in the majority of samples and measurements were not localized to pre-mineralized tissues. Replacement of muscle with collagen can be interpreted as an early sign of tissue endochondral ossification detectable via Raman spectroscopy once proliferative chondrocytes are present. Prior to the appearance of chondrocytes at the site of injury, vehicle control rats exhibit signs of altered fibrin accumulation as early as 24 h following injury. Fibrin production is necessary to stop hemorrhage following traumatic injury; however hypercoagulability and fibrin accumulation has been associated with neurogenic HO formation 33, 34 and the role of impaired fibrinolysis has been implicated in HO formation. 35 Significantly increased IL-17 in Palovarotene treated animals at POD-1 and 3 may induce prostaglandin production which in turn prevents excessive clot formation.
While these findings provide additional insight into the mechanism of action of Palovarotene, there are a number of limitations which should be addressed in future studies. There was no increase in the number of wound healing complications in Palovarotene treated animals in the present study; however, previous studies have reported this complication. 21 Additionally, at this point it is unclear what effects Palovarotene would have on normal bone healing. A more thorough examination of the potential side effects of Palovarotene should be performed, especially in a poly-trauma setting which may be complicated by multiple healing fractures or large, tenuous wounds. Furthermore, detailed histological assessment of early fibrinoid accumulation following injury and its role in the initiation of chondrogenesis is warranted. Lastly, while we speculate the cause of increased cellular infiltration following injury is primarily due to the recruitment of inflammatory cells, we cannot definitively prove this with the available data. Additional studies should be performed to characterize the cellular populations present.
Taken together, these findings suggest that Palovarotene may act through three interrelated mechanisms to inhibit HO formation. First, it exhibits anti-inflammatory effects both systemically and locally. Second, a dose-dependent anti-proliferative effect on progenitor cells, and third, modulation of expression of genes involved in chondrogenesis, osteogenesis and tissue remodeling. A combination of these three mechanisms at early time points following injury ultimately results in a significant reduction in the formation of mature ectopic bone, as has been previously shown. 21 Additionally, spectroscopic evidence of fibrin accumulation within the first 48 h following injury may potentially serve as an early diagnostic marker of HO formation prior to radiographic evidence of endochondral ossification. Raman spectroscopy may serve as an important tool in monitoring early HO development and pathogenesis as well as to provide predictive value when combined with clinical markers.
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